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Though the experimental studies on the activation of
“photodynamic” medications was only published 1999,
the FDA approved the use of the ALA (Aminolevulinic)
in the dermatologic field.
In substance, the PDT by using photosensitive medi-
cines at a topical level (ALA and MAL), a luminous
source with an appropriate wavelength for their activa-
tion, set the formation of protoporphyrin IX and when it
returns to its native state, reacts with molecular oxygen
and forms reactive species like the “singoletto” oxygen.
The formation of this substance is to the base of the
fall events that may lead to the destruction of the cellule
through the:
￿ apoptosis, the damage of the mitochondrial and
cell membranes
￿ damage of the endothelium from the oxygen
radicals
￿ inflammatory process
￿ induction of the immune answer
The PDT is a valid alternative to chirurgic treatment
for the basocellular epitelioma and actinic keratosis
when subsist particular health conditions of the patient
or when the number and the centre of the wounds
make the chirurgic act hard to be applied.
After personal experiences have been reported, we will
speak of the advantages and disadvantages of the method
and for which patients this cure is recommended.
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